CausalSentinel

Protein Dossier — ADGRE2 (Adhesion G protein-coupled receptor E2)

MR feasibility tier: A — Published pQTL-MR estimates exist for this protein (retrieved below - not computed here).

1. Published MR estimates (retrieved, not computed)

Outcome beta se p method nSNP cis/trans coloc
Diagnoses - main ICD10: D25 Leiomyoma of uterus 0.265 0.0606 1.24e-05 Wald ratio 1 cis NA
Diagnoses - main ICD10: K44 Diaphragmatic hernia 0.16 0.0611 0.00879 Wald ratio 1 cis NA
Neo-extraversion -0.822 0.352 0.0195 Wald ratio 1 cis NA
Diagnoses - main ICD10: B37 Candidiasis 0.553 0.266 0.0376 Wald ratio 1 cis NA
Height 0.0313 0.0155 0.0432 Wald ratio 1 cis NA
Birth weight -0.0293 0.0152 0.0532 Wald ratio 1 cis NA
Neo-conscientiousness -0.67 0.347 0.0532 Wald ratio 1 cis NA
Diagnoses - main ICD10: K29 Gastritis and duodenitis 0.0957 0.0526 0.0688 Wald ratio 1 cis NA
Low grade serous ovarian cancer 0.353 0.2 0.0782 Wald ratio 1 cis NA
Diagnoses - main ICD10: Z09 Follow-up examination after treatment for conditions other than malignant neoplasms 0.114 0.0651 0.0807 Wald ratio 1 cis NA
Non-cancer illness code self-reported: sleep apnoea 0.227 0.131 0.082 Wald ratio 1 cis NA
Diagnoses - main ICD10: N20 Calculus of kidney and ureter -0.24 0.138 0.0823 Wald ratio 1 cis NA
…and 92 more outcomes (see JSON)              

2. pQTL instrument availability (Tier-B probe)

Dataset Trait Author Year
prot-c-4546_27_3 EMR2 Suhre K 2019

3. GWAS Catalog results — traits with signal at this locus

11 association rows across 10 traits (4 genome-wide significant rows). Associations are loci, not causal claims; the mapped gene at a locus is not necessarily the effector gene.

Trait best p lead SNP n assoc study MR status  
Adhesion G protein-coupled receptor E2 levels 2e-339 rs9305048 2 GCST90426071 no MR -> candidate analysis  
Protein quantitative trait loci (liver) 2e-8 rs117617387 1 GCST011427 no MR -> candidate analysis  
Height 2e-8 rs2732796 1 GCST90245844 MR: beta=0.0313, p=0.0432 (cis)  
Peak concentration of apixaban 5e-8 rs553498034 1 GCST90271720 no MR -> candidate analysis  
Plasma androstenedione levels in resected early stage-recept 1e-7 rs57712673 1 GCST004363 no MR -> candidate analysis  
2-hydroxypalmitate levels in elite athletes 3e-7 rs3795033 1 GCST90133637 no MR -> candidate analysis  
Major depressive disorder 1e-6 rs112610420 1 GCST005547 no MR -> candidate analysis  
Vaginal microbiome MetaCyc pathway (PWY-7007 methyl ketone b 1e-6 rs4808487 1 GCST90026898 no MR -> candidate analysis
Response to gabapentin in female chronic pelvic pain (side-e 2e-6 rs11666594 1 GCST90428069 no MR -> candidate analysis  
Parkinson’s disease motor subtype (tremor to postural instab 3e-6 rs538015403 1 GCST90000015 no MR -> candidate analysis  

4. Phenome map — where this gene is a genetic locus, vs. where MR exists

Top diseases by Open Targets association (of 154 total). Associations are loci, not causal claims. The causal-status column is a four-state triage per pair: established (curated) = a curated clinical assertion exists (ClinGen/G2P/GEL/Orphanet/ClinVar — any validity level, MR adds little); exploratory rare-variant signal = ExWAS burden evidence without curation — a candidate NEW gene-disease relationship; common-variant locus = GWAS signal, classic pQTL-MR territory; multi-layer = burden+GWAS together, an allelic-series candidate (the strongest causal setup). Burden estimand is carrier-vs-noncarrier, not per-SD MR.

Disease genetic assoc. burden (ExWAS) causal status MR status
vibratory urticaria 0.688 established (curated) no MR -> candidate analysis
autosomal dominant vibratory urticaria 0.545 established (curated) no MR -> candidate analysis
Genetic visceral malformation of the liver, biliary tract, pancreas or spleen 0.267 common-variant locus no MR -> candidate analysis

Of the 3 rows above, 3 have no MR estimate in this resource. Across all retrieved diseases for this gene: 0 exploratory rare-variant signal(s), 0 multi-layer (allelic-series candidate) pair(s). Final triage still belongs to a statistical geneticist.

5. Downstream annotation (druggability & safety preview)

Layer Result
ChEMBL druggability not available — no ChEMBL target (undrugged)
gnomAD constraint pLI=1.9e-23, LOEUF=0.988 — LoF-tolerant
GWAS Catalog 30 unique SNPs / 58 rows
ClinVar 701 records; 0 pathogenic in sample of 30
PharmGKB/ClinPGx no annotations

Caveats declared by the tools

Sources

Provenance